These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 10946236)

  • 1. The BRCA1 C-terminal domain: structure and function.
    Huyton T; Bates PA; Zhang X; Sternberg MJ; Freemont PS
    Mutat Res; 2000 Aug; 460(3-4):319-32. PubMed ID: 10946236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
    Rodriguez M; Yu X; Chen J; Songyang Z
    J Biol Chem; 2003 Dec; 278(52):52914-8. PubMed ID: 14578343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins.
    Bork P; Hofmann K; Bucher P; Neuwald AF; Altschul SF; Koonin EV
    FASEB J; 1997 Jan; 11(1):68-76. PubMed ID: 9034168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCT domain interactions in the heterodimeric DNA repair protein XRCC1-DNA ligase III.
    Dulic A; Bates PA; Zhang X; Martin SR; Freemont PS; Lindahl T; Barnes DE
    Biochemistry; 2001 May; 40(20):5906-13. PubMed ID: 11352725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure and backbone dynamics of the human DNA ligase IIIalpha BRCT domain.
    Krishnan VV; Thornton KH; Thelen MP; Cosman M
    Biochemistry; 2001 Nov; 40(44):13158-66. PubMed ID: 11683624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between BRCT repeats and phosphoproteins: tangled up in two.
    Glover JN; Williams RS; Lee MS
    Trends Biochem Sci; 2004 Nov; 29(11):579-85. PubMed ID: 15501676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BRCT domain is a phospho-protein binding domain.
    Yu X; Chini CC; He M; Mer G; Chen J
    Science; 2003 Oct; 302(5645):639-42. PubMed ID: 14576433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.
    Williams RS; Green R; Glover JN
    Nat Struct Biol; 2001 Oct; 8(10):838-42. PubMed ID: 11573086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of a BRCT domain in the interaction of DNA ligase III-alpha with the DNA repair protein XRCC1.
    Taylor RM; Wickstead B; Cronin S; Caldecott KW
    Curr Biol; 1998 Jul; 8(15):877-80. PubMed ID: 9705932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The FHA and BRCT domains recognize ADP-ribosylation during DNA damage response.
    Li M; Lu LY; Yang CY; Wang S; Yu X
    Genes Dev; 2013 Aug; 27(16):1752-68. PubMed ID: 23964092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling.
    Shiozaki EN; Gu L; Yan N; Shi Y
    Mol Cell; 2004 May; 14(3):405-12. PubMed ID: 15125843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure.
    Joo WS; Jeffrey PD; Cantor SB; Finnin MS; Livingston DM; Pavletich NP
    Genes Dev; 2002 Mar; 16(5):583-93. PubMed ID: 11877378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of an XRCC1 BRCT domain: a new protein-protein interaction module.
    Zhang X; Moréra S; Bates PA; Whitehead PC; Coffer AI; Hainbucher K; Nash RA; Sternberg MJ; Lindahl T; Freemont PS
    EMBO J; 1998 Nov; 17(21):6404-11. PubMed ID: 9799248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations.
    Williams RS; Chasman DI; Hau DD; Hui B; Lau AY; Glover JN
    J Biol Chem; 2003 Dec; 278(52):53007-16. PubMed ID: 14534301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of a novel mutation in exon 20 of the BRCA1 gene.
    Chakraborty A; Katarkar A; Chaudhuri K; Mukhopadhyay A; Basak J
    Cell Mol Biol Lett; 2013 Dec; 18(4):631-8. PubMed ID: 24297685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural consequences of a cancer-causing BRCA1-BRCT missense mutation.
    Williams RS; Glover JN
    J Biol Chem; 2003 Jan; 278(4):2630-5. PubMed ID: 12427738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the BARD1 BRCT domains.
    Birrane G; Varma AK; Soni A; Ladias JA
    Biochemistry; 2007 Jul; 46(26):7706-12. PubMed ID: 17550235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boundaries and physical characterization of a new domain shared between mammalian 53BP1 and yeast Rad9 checkpoint proteins.
    Alpha-Bazin B; Lorphelin A; Nozerand N; Charier G; Marchetti C; Bérenguer F; Couprie J; Gilquin B; Zinn-Justin S; Quéméneur E
    Protein Sci; 2005 Jul; 14(7):1827-39. PubMed ID: 15987907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
    Tischkowitz M; Hamel N; Carvalho MA; Birrane G; Soni A; van Beers EH; Joosse SA; Wong N; Novak D; Quenneville LA; Grist SA; ; Nederlof PM; Goldgar DE; Tavtigian SV; Monteiro AN; Ladias JA; Foulkes WD
    Eur J Hum Genet; 2008 Jul; 16(7):820-32. PubMed ID: 18285836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer predisposing mutations in BRCT domains.
    di Masi A; Gullotta F; Cappadonna V; Leboffe L; Ascenzi P
    IUBMB Life; 2011 Jul; 63(7):503-12. PubMed ID: 21698754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.